Wyden showdown at hand

Scripps, NIH ready to discuss technology transfer deals

By Kris Herbst
Contributing Editor

WASHINGTON - Testimony by NIH Director Bernadine Healy and representatives of The Scripps Research Institute and Sandoz Pharmaceuticals Corp. will culminate several weeks of harried investigation on Thursday as Rep. Ron Wyden launches a new round of hearings on whether the federal government should impose price restraints on companies that enter into partnerships with federally supported research institutions.